Apt Medical Inc. (688617.SH): Obtained medical instrument registration certificate for embolization spring coil.
Apt Medical Inc. (688617.SH) announced that its wholly-owned subsidiary, Hunan Apt Medical Instruments Co., Ltd., has obtained a medical instrument registration certificate for the product named Embolization Spring Coil. The acquisition of the aforementioned medical instrument registration certificate is conducive to enriching the company's product range, expanding its product layout in the peripheral field, continuously meeting diverse clinical demands, and further enhancing the company's core competitiveness.
Why The 29% Return On Capital At APT Medical (SHSE:688617) Should Have Your Attention
SSE Science and Technology Innovation Board 50 Index sample adjustment: apt medical inc. (688617.SH), Company 9 (689009.SH) included in the adjustment.
On August 30th, according to the index rules, the Shanghai Stock Exchange and China Securities Index Co., Ltd. decided to adjust the sample of the SSE Science and Technology Innovation Board 50 Index, which will take effect after the market closes on September 13, 2024.
APT Medical's H1 Profit Rises 33%, Operating Income Climbs 27%; Shares Drop 3%
Half-year report for the year 2024.
Summary of Half-Year Report in 2024.
Southwest Securities: How to view the investment opportunities and challenges of high-value consumables in the post-medicine group purchase era?
In the context of centralized procurement, most areas in the high-value consumables field are currently highly competitive and have limited growth potential. Therefore, the tracks with low penetration rates and low localization rates have long-term growth potential.
Is APT Medical (SHSE:688617) Using Too Much Debt?
APT Medical Gets Registration Certificate for Catheter
Apt Medical Inc. (688617.SH): Obtained the Medical Instrument Registration Certificate for Disposable Magnetic Positioning Ring Marker Catheter.
Apt Medical Inc. (688617.SH) announced on August 7th that the company has obtained a medical instrument registration certificate for a disposable magnetic positioning ring marker catheter. The acquisition of this registration certificate for medical instruments helps enrich the variety of products offered by the company, expanding the company's product layout in the field of cardiac electrophysiology, continuously meeting diverse clinical needs, and further enhancing the company's core competitiveness.
Risks Still Elevated At These Prices As APT Medical Inc. (SHSE:688617) Shares Dive 27%
Apt Medical Inc. (688617.SH) plans to distribute 20 yuan per 10 shares and convert 4.5 shares on July 26th, 2023.
Apt Medical Inc. (688617.SH) announced the company's plan to distribute a cash dividend of RMB 1.0 (tax included) per 10 shares to all shareholders for the year 2023.
APT Medical Inc.'s (SHSE:688617) Stock Has Fared Decently: Is the Market Following Strong Financials?
Institutional Investors in APT Medical Inc. (SHSE:688617) See CN¥2.3b Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
Cathay Pacific Junan: The valuation level of the normalized mining industry is expected to rise
The Zhitong Finance App learned that Guotai Junan released a research report saying that in recent years, the quality of collection has been improved and expanded. Along with this, the design of collection rules has been continuously improved, and the results are more moderate and predictable. The results of this joint China Mining contract renewal have provided further verification. As the negative effects of traditional product collection are gradually clarified, emerging varieties are rapidly being admitted to hospital through collection. The number of surgeries is expected to continue to grow under the combined impetus of factors such as an aging population, increased public health awareness, and more mature procedures. The high-value consumables industry is also expected to continue to flourish on a new base, and the industry's valuation level is expected to rise. Maintain Elken Healthcare (0178
Some Shareholders Feeling Restless Over APT Medical Inc.'s (SHSE:688617) P/E Ratio
Mindray Healthcare (300760.SZ) obtains control of Huitai Healthcare
Mindray Healthcare (300760.SZ) announced that as of the date of this announcement, Cheng Zhenghui held Huitai Medical 1251.9...
Huitai Healthcare (688617.SH) announced first-quarter results, net profit of 140 million yuan, up 36.48% year-on-year
Huitai Healthcare (688617.SH) released its report for the first quarter of 2024. The company achieved operating income of 4 during the reporting period...
Huitai Medical (688617.SH)'s wholly-owned subsidiary obtained a medical device registration certificate
Huitai Medical (688617.SH) announced, April 19, 2024, Hunan Ept, a wholly-owned subsidiary of the company...
Calculating The Fair Value Of APT Medical Inc. (SHSE:688617)
No Data
No Data